Cost-Effectiveness Analysis in Markets with High Fixed Costs

Author： Cutler David M.   Ericson Keith M. Marzilli  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.28, Iss.10, 2010-10, pp. : 867-875

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Estimating `Costs' for Cost-Effectiveness Analysis

By Miners Alec  

PharmacoEconomics, Vol. 26, Iss. 9, 2008-01 ,pp. : 745-751

Adis International

Access to resources Recommend Favorite

Cost–effectiveness analysis in pharmacogenomics

By Payne Katherine   Shabaruddin Fatiha H  

Pharmacogenomics, Vol. 11, Iss. 5, 2010-05 ,pp. : 643-646

Future Medicine

Access to resources Recommend Favorite

Subgroups and Heterogeneity in Cost-Effectiveness Analysis

By Sculpher Mark  

PharmacoEconomics, Vol. 26, Iss. 9, 2008-01 ,pp. : 799-806

Adis International

Access to resources Recommend Favorite

Exploring Uncertainty in Cost-Effectiveness Analysis

By Claxton Karl  

PharmacoEconomics, Vol. 26, Iss. 9, 2008-01 ,pp. : 781-798

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of Therapies for Chronic Kidney Disease Patients on Dialysis: A Case for Excluding Dialysis Costs

By Grima Daniel T.  

PharmacoEconomics, Vol. 30, Iss. 11, 2012-11 ,pp. : 981-989

Adis International

Access to resources Recommend Favorite